Analyst Price Target is $52.67
▲ +177.19% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Tourmaline Bio in the last 3 months. The average price target is $52.67, with a high forecast of $65.00 and a low forecast of $43.00. The average price target represents a 177.19% upside from the last price of $19.00.
Current Consensus is
The current consensus among 3 contributing investment analysts is to buy stock in Tourmaline Bio. This Buy consensus rating has held steady for over two years.